BIOWKS — Bio-Works Technologies AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK310.39m
- SEK275.46m
- SEK62.50m
Annual cashflow statement for Bio-Works Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.84 | -46.1 | -56.3 | -38 | -17.5 |
| Depreciation | |||||
| Non-Cash Items | 0.418 | 1.08 | 0 | 0.125 | -0.192 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.7 | 4.67 | -3.25 | -5.81 | -1.61 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13.4 | -39.9 | -59 | -43.2 | -18.8 |
| Capital Expenditures | -0.942 | -1.12 | -0.86 | -0.008 | -0.404 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0.166 | 0 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.942 | -1.12 | -0.86 | 0.158 | -0.404 |
| Financing Cash Flow Items | -2.71 | -0.132 | -0.027 | -1.23 | -0.181 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 84 | 4.04 | 33.3 | 37.8 | 20.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 69.7 | -36.9 | -26.5 | -5.1 | 0.654 |